Natco seeks CDSCO approval for phase-III trial of Molnupiravir for Covid-19 treatment
Natco seeks CDSCO approval for phase-III trial of Molnupiravir for Covid-19 treatment Natco Pharma has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of phase-III clinical trial of Molnupiravir capsules for the treatment of Covid-19 positive patients. https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment